NOTCH1 inhibition enhances immunogenicity and sensitizes triple-negative breast cancer to immune checkpoint inhibitors. Gao Y, Zuo L, Zheng Y, Sun K, et al. Breast Cancer Res 2025;27:92.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gao Y, Zuo L, Zheng Y, Sun K, et al. NOTCH1 inhibition enhances immunogenicity and sensitizes triple-negative breast cancer to immune checkpoint inhibitors. Breast Cancer Res 2025;27:92.
PMID: 40420289